ICMR wins the 2017 Kochon Prize for TB research
The Indian Council of Medical Research (ICMR) has won the Stop TB Kochon Prize for excellence in TB research and development. The $65,000
Read MoreThe Indian Council of Medical Research (ICMR) has won the Stop TB Kochon Prize for excellence in TB research and development. The $65,000
Read MoreIn a Phase III trial, delamanid drug was found to be safe but the cure rate and mortality rate were
Read MoreDelhi and Punjab have introduced HPV vaccination and are expanding it, while a few States have shown interest. And the
Read MoreIn Phase III trial, Serum Institute’s rotavirus vaccine (ROTASIIL) was found to have nearly 55% efficacy against the very severe
Read MoreRi Scarborough, Monash University Throughout the era of modern medicine, animals have been used extensively to develop and test therapies
Read MoreThe Hyderabad-based Bharat Biotech has begun a Phase I human clinical trial of the indigenously developed chikungunya vaccine three months
Read MoreZika is an arbovirus infection which occurs through the bite of several different species of Aedes mosquitoes, including the Aedes
Read MoreBeginning next year, the World Health Organisation will begin pilot tests of the injectable malaria vaccine RTS,S (or Mosquirix) on
Read MoreBharat Biotech International Ltd in Hyderabad will start a Phase I clinical trial of Zika virus vaccine (MR 766) in
Read MoreThe Hyderabad-based Bharat Biotech’s killed (inactivated) Zika virus vaccine using an African strain (MR 766) has shown 100% efficacy against
Read MoreIn June this year, the Pune-based Serum Institute of India Pvt Limited will begin a Phase II/III vaccine trial for
Read MoreIndian researchers have been able to bring about more than 50-fold improvement in the efficacy of the commonly used TB
Read MoreResearchers at the Pune-based National Centre for Cell Science (NCCS) have been successful in isolating cancer stem cells that cause
Read More